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of up to 112µm. Histological features of the subchondral bone
resorption pits were analysed with H&E staining. Tartrate resis-
tant acid phosphatase (TRAP) positive cells were identiﬁed by
immunohistochemsitry. Normal cartilage and subchondral bone
were obtained from femoral heads at post mortem from cadavers
with no clinical history of OA (n = 9).
Results: Resorption pits were divided into ﬁve groups which
were classiﬁed by morphological phenotype based on the con-
tent of cells present within the pit and the location of the pit within
the subchondral/calciﬁed cartilage space. All resorption pits ex-
amined contained TRAP positive osteoclast-like cells indicating
the destructive nature of these lesions. The concurrent presence
of osteoblasts and osteoclasts within the resorption pits suggests
the involvement of the resorption pits in the process of bone
remodelling and possibly sclerosis. Histological analysis of sam-
ples suggested that resorption pits may arise from the normal
pit structure that is seen within the subchondral plate and may
extend through a process of bone resorption and remodelling,
to involve a larger area of the subchondral region and encroach
on overlying calciﬁed and articular cartilage. 3D reconstruction
of subchondral bone resorption pits demonstrated a branching
morphology with smaller pits interlinking with a larger resorption
pit which linked with bone marrow. This branching morphology
suggesting possible development of resorption pits through pre-
existing vascular channels or the interaction of bridging areas of
bone resorption.
Conclusions: Subchondral bone resorption pits can be classi-
ﬁed into various types based on their morphology; these separate
classiﬁcations may represent a development sequence from fo-
cal (normal) areas of endochondral ossiﬁcation or expansion of
bone vascular channels. The extensive nature of these lesions
may also be a reﬂection of altered biomechanical stresses on the
subchondral plate and may, in turn, contribute to altered bone
responses and joint instability in OA.
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Purpose: Transforming growth factor-β (TGF-β) is a multifunc-
tional regulator of chondrocyte proliferation, differentiation and
extracellular matrix production. Dysregulation of TGF-β action
has been implicated in cartilage diseases such as osteoarthritis.
TGF-β signaling is transduced through a pair of transmembrane
serine/threonine kinases, known as the type I (ALK5) and type
II (TβRII) receptors. Activation of ALK5 leads to phosphoryla-
tion of intracellular Smad2 and Smad3, which associate with
the common Smad4 and then translocate to the nucleus where
they interact with coactivators and/or corepressors to modulate
expression of target genes in a cell-speciﬁc manner. However,
recent studies on endothelial cells have identiﬁed another TGF-β
type I receptor named ALK1, and its activation does not lead
to phosphorylation of Smad2 or Smad3, but instead leads to
phosphorylation of Smad1, 5 and 8. The goal of this study
was to determine if ALK1 is expressed in human chondrocytes
and to characterize its role in regulation of TGF-β signaling and
responses in human chondrocytes.
Methods: ALK1 mRNA and protein expression in human chon-
drocytes were examined by RT-PCR and Western blotting. The
interaction of ALK1 with other TGF-β receptor components was
studies by (1) [125I]TGF-β1 afﬁnity labeling of cell surface recep-
tors followed by immunoprecipitation with TGF-β receptor spe-
ciﬁc antibodies and (2) immunoprecipitation of unlabeled TGF-β
receptors followed by Western blotting using an anti-HA anti-
body to detect exogenously expressed ALK1-HA. The functional
role of ALK1 in regulation of TGF-β1-induced signaling and re-
sponses was examined by gain and loss of function studies.
Human chondrocytes overexpressing ALK1 or in which endoge-
nous ALK1 levels were reduced by ALK1 siRNA knockdown
were examined for their responsiveness to TGF-β1 by measuring
transcriptional activity (3TP-lux), Smad3-speciﬁc transcriptional
activity (CAGA12-lux), Smad1/5 and Smad3 phosphorylation and
expression levels of extracellular matrix components (type II
collagen, PAI-1 and ﬁbronectin).
Results: ALK1 mRNA and protein expression were demon-
strated in human chondrocytes. ALK1 was shown to be a com-
ponent of the TGF-β receptor system in human chondrocytes,
as evidenced by its interaction with ALK5, TβRII, endoglin and
betaglycan in the presence or absence of TGF-β1 ligand. Our
results indicate that both ALK1 and ALK5 are required for TGF-
β-induced phosphorylation of Smad1/5 whereas only ALK5 is
essential for TGF-β1-induced phosphorylation of Smad3 in these
cells. In addition, our results demonstrate that ALK1 inhibits,
while ALK5 potentiates, TGF-β-induced Smad3-driven transcrip-
tional activity and the expression of PAI-1, ﬁbronectin and type II
collagen.
Conclusions: Our results suggest that, in human chondrocytes,
TGF-β signals through two TGF-β type I receptors: ALK1 and
ALK5. Activation of the ALK5 pathway leads to activation of the
Smad3 pathway and increased expression of extracellular matrix
components, PAI-1, ﬁbronectin and type II collagen, whereas
activation of the ALK1 pathway opposes these functions. Our
study suggests that ALK1 plays an essential role in the regulation
of TGF-β signaling and function in the human cartilage.
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Purpose: The serine protease HtrA1 (also referred to as
PRSS11) has been shown to be one of the most abundant
proteases in cartilage, wherein its levels are upregulated during
osteoarthritis (OA). A hexapeptide derived from the C-terminus
of procollagen type II (and type III), designated CPII, has previ-
ously been shown to stimulate HtrA1 protease activity by tightly
interacting with its PDZ domain. The purpose of this study was
to investigate HtrA1-mediated cleavage of aggrecan and the ag-
onistic effect of CPII on HtrA1 activity, and to better understand
the role of HtrA1 in OA disease progression.
Methods: Identiﬁcation of potential HtrA1 substrates: Wildtype
HtrA1 (amino acids 157-480) and an inactive HtrA1 mutant
(S328A) were overexpressed in 3-D alginate cultures of primary
human chondrocytes. A mass spectrometry-based method was
utilized to identify potential HtrA1-generated cleavage products
released into the culture medium. In vitro cleavage of aggrecan:
Puriﬁed human aggrecan and recombinant aggrecan constructs
comprising either the G1-interglobular domain (IGD)-G2 or IGD
alone were incubated with puriﬁed recombinant HtrA1 (aa 157-
480) or an inactive HtrA1 mutant (aa 157-480, S328A). A control
peptide or CPII was added to the reactions to evaluate potential
